Section I
51 – 60 of 5047
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy : Results from the prospective GHSG–NLG phase II BVB trial
- Contribution to journal › Letter
-
Mark
Association of Circulating Inflammatory Biomarker Levels and Toxicity in Patients Undergoing Pelvic Radiation for Cancer : A Critical Review
- Contribution to journal › Scientific review
-
Mark
Balancing Environmental Sustainability and Nutrition: Dietary Climate Impact in Relation to Micronutrient Intake and Status in a Swedish Cohort
- Contribution to journal › Article
-
Mark
Pancreatic Adenocarcinoma : Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
- Contribution to journal › Article
-
Mark
Pre- or postoperative radiotherapy for oral cancer - Does the treatment order matter?
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
LUND-PROBE – LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset
- Contribution to journal › Article
-
Mark
Development and validation of prediction models for sentinel lymph node status indicating postmastectomy radiotherapy in breast cancer : population-based study
- Contribution to journal › Article
-
Mark
High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes
- Contribution to journal › Article
-
Mark
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
- Contribution to journal › Article
-
Mark
Impact of the risk-adapted Nordic anal cancer group consensus guidelines on the contouring of the elective clinical target volume in anal cancer
- Contribution to journal › Article
